Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label)
Published August 20, 2025 · Recall initiated: July 21, 2025
Summary
FDA records drug Class II recall D-0584-2025, published August 20, 2025 and initiated July 21, 2025. Recalling firm: Merck & Co. Inc; Status: Ongoing; Reported quantity: 51,320 cartons; Lot: Lots 2090019 and 2123744, Exp. 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
What to do
Voluntary: Firm initiated
Get an email if BELSOMRA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BELSOMRA
- Manufacturer
- Merck & Co. Inc
- Distributor
- Nationwide in the USA and PR.
- Lot
- Lots 2090019 and 2123744, Exp. 4/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATheophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: GlenmarkAugust 20, 2025
- FDALactated Ringer's Injection USP, L 7500, 1000mL Excel Container, Rx Only, Sterile, nonpyrogenic, single doseAugust 20, 2025
- FDAMetoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General PlantAugust 20, 2025
- FDA0.9% Sodium Chloride Injection USP, L 8000, 1000mL Excel Container, Rx Only, Sterile, nonpyrogenic, singleAugust 20, 2025
- FDAMetoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General PlantAugust 20, 2025
- FDABelsomra (suvorexant) tablets 20 mg Each tablet contains 20 mg suvorexant. This package contains 30 Tablets inJune 2, 2021
Questions about this recall
Was Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label) recalled?
Yes. FDA published recall D-0584-2025 on August 20, 2025. Reported hazard: Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BELSOMRA.